Module 2: Pharmacologic Management of Obesity

Target Audience

The target audience for this program includes physicians, advanced practice providers, and other clinicians who care for obese patients.

Learning Objectives

After participating in this education, learners will be able to:

  1. Review available pharmacological options for obesity, their efficacy, dosing, and side effects.

Course summary
Available credit: 
  • 0.25 AANP (American Association of Nurse Practitioners)

    This activity is approved for 0.25 contact hour(s) of continuing education (which includes 0.25 hour(s) of pharmacology) by the American Association of Nurse Practitioners. .

    This activity was planned in accordance with AANP Accreditation Standards and Policies.

  • 0.25 AAPA

    This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit(s). PAs should only claim credit commensurate with the extent of their participation.

    This activity was planned in accordance with AAPA CME Criteria for Live Programs and for Commercial Support of Live Programs.

  • 0.25 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Enduring activity is designated for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 0.25 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 nursing contact hour(s).

  • 0.25 IPCE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

  • 0.25 Participation
    UK Healthcare CECentral certifies this activity for 0.25 hour(s) of participation.
Course opens: 
11/15/2025
Course expires: 
11/14/2026
Part of: 
Tackling Obesity in Appalachian Healthcare: Approaches, Challenges, and Solutions
Rating: 
0
CECentral
Lexington, KY
United States
Speaker(s)

Caitlin Davidson, DNP, APRN, FNP-C

has no relevant financial relationships to disclose at this time.

Stephanie Rose, MD, MPH

has no relevant financial relationships to disclose at this time.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.
 
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
 
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Available Credit

  • 0.25 AANP (American Association of Nurse Practitioners)

    This activity is approved for 0.25 contact hour(s) of continuing education (which includes 0.25 hour(s) of pharmacology) by the American Association of Nurse Practitioners. .

    This activity was planned in accordance with AANP Accreditation Standards and Policies.

  • 0.25 AAPA

    This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credit(s). PAs should only claim credit commensurate with the extent of their participation.

    This activity was planned in accordance with AAPA CME Criteria for Live Programs and for Commercial Support of Live Programs.

  • 0.25 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Enduring activity is designated for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 0.25 ANCC (UK Healthcare CECentral)

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 nursing contact hour(s).

  • 0.25 IPCE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

  • 0.25 Participation
    UK Healthcare CECentral certifies this activity for 0.25 hour(s) of participation.
Please login or register to take this course.